| Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine SS Bashraheel, A Domling, SK Goda Biomedicine & Pharmacotherapy 125, 110009, 2020 | 116 | 2020 |
| Production of “biobetter” glucarpidase variants to improve drug detoxification and antibody directed enzyme prodrug therapy for cancer treatment AD AlQahtani, L Al-Mansoori, SS Bashraheel, FB Rashidi, A Al-Yafei, ... European Journal of Pharmaceutical Sciences 127, 79-91, 2019 | 30 | 2019 |
| Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment FB Rashidi, AD AlQhatani, SS Bashraheel, S Shaabani, MR Groves, ... PLoS One 13 (4), e0196254, 2018 | 26 | 2018 |
| Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications SS Bashraheel, H Kheraldine, S Khalaf, AE Al Moustafa Biomedicine & Pharmacotherapy 162, 114676, 2023 | 17 | 2023 |
| Production of “biobetter” variants of glucarpidase with enhanced enzyme activity AD Al-Qahtani, SS Bashraheel, FB Rashidi, CD O’Connor, AR Romero, ... Biomedicine & Pharmacotherapy 112, 108725, 2019 | 14 | 2019 |
| In vitro studies on CNGRC-CPG2 fusion proteins for ligand-directed enzyme prodrug therapy for targeted cancer therapy L Al-Mansoori, SS Bashraheel, AD Al Qahtani, CD O’Connor, P Elsinga, ... Oncotarget 11 (6), 619, 2020 | 9 | 2020 |
| Studies on vascular response to full superantigens and superantigen derived peptides: Possible production of novel superantigen variants with less vasodilation effect for … SS Bashraheel, AD AlQahtani, FB Rashidi, H Al-Sulaiti, A Domling, ... Biomedicine & Pharmacotherapy 115, 108905, 2019 | 9 | 2019 |
| Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study K Naja, N Anwardeen, SS Bashraheel, MA Elrayess Journal of Pharmacy & Pharmaceutical Sciences 27, 13305, 2024 | 1 | 2024 |
| Generation of Novel Tumour-Selective SEA Superantigen-Based Peptides with Improved Safety and Efficacy for Precision Cancer Immunotherapy SS Bashraheel, H Al-Sulaiti, SK Goda International Journal of Molecular Sciences 25 (17), 9423, 2024 | 1 | 2024 |
| Alterations in Choline Metabolism in Non-Obese Individuals with Insulin Resistance and Type 2 Diabetes Mellitus H Al-Sulaiti, N Anwardeen, SS Bashraheel, K Naja, MA Elrayess Metabolites 14 (8), 2024 | 1 | 2024 |
| Novel SPEA Superantigen Peptide Agonists and Peptide Agonist-TGFαL3 Conjugate. In Vitro Study of Their Growth-Inhibitory Effects for Targeted Cancer Immunotherapy SS Bashraheel, SK Goda International Journal of Molecular Sciences 24 (13), 10507, 2023 | 1 | 2023 |
| Metabolic signatures of combined exercise and fasting: an expanded perspective on previous telomere length findings S Almuraikhy, K Naja, N Anwardeen, M Sellami, HS Al-Amri, H Al-Sulaiti, ... Frontiers in Aging 5, 1494095, 2024 | | 2024 |
| Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment (vol 13, e0196254, 2018) FB Rashidi, AD Al-Qahtani, SS Bashraheel, S Shaabani, MR Groves, ... PLOS ONE 18 (11), 2023 | | 2023 |
| Correction: Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment FB Rashidi, AD Al-Qahtani, SS Bashraheel, S Shaabani, MR Groves, ... Plos one 18 (11), e0294885, 2023 | | 2023 |
| Studies on Superantigens and Antibody Directed Enzyme Prodrug Therapy for Tolerable Targeted Cancer Treatment S Bashraheel | | 2019 |
| Production of “biobetter” variants of glucarpidase with enhanced enzyme activity SS Bashraheel, AD Al-Qahtani, FB Rashidi, CD O’Connor, AR Romero, ... Studies on Superantigens and Antibody Directed Enzyme Prodrug Therapy for …, 2019 | | 2019 |
| Cloning, Overexpression And Molecular Characterization Of Four Superantigens: Production Of Protein Therapeutics For Cancer Treatment S Bashraheel, H Al Sulaiti, A Alqahtani, M Jaganijac, W Helfrich, SK Goda Qatar Foundation Annual Research Conference Proceedings Volume 2014 Issue 1 …, 2014 | | 2014 |
| Functional overexpression and purification of a codon optimized synthetic four superantigens in Escherichia coli: Production of superantigens with improved safety and efficacy … S Bashraheel, A Al‐Qahtani, H Al‐Sulaiti, A Al‐thani, S Goda The FASEB Journal 28, LB582, 2014 | | 2014 |
| Studies on Vascular Response to Full Superantigens and Superantigen Derived SS Bashraheel, AD Al Qahtani, FB Rashidi, H Al-Sulaiti, A Domling, ... Production of Novel Protein Therapeutics to Improve Targeted Cancer Therapy, 179, 0 | | |
| Production of “biobetter” glucarpidase variants to improve drug detoxification and antibody directed enzyme prodrug therapy for cancer treatment. L Al-mansoori, AD AlQhatani, SS Bashraheel, FB Rashidi, A Al-Yafei, ... | | |
Sayed K GodaUniversity of Derby and Southampton University, UKVerified email at derby.ac.uk
